Ethical Considerations of Omitting Genital Examination During Skin Cancer Screening

By afschroeder • May 1, 2026

Chou P, Lee K, Grant-Kels JM, Farshchian M. Ethical Considerations of Omitting Genital Examination During Skin Cancer Screening. J Am Acad Dermatol. 2026 Apr 28:S0190-9622(26)02571-5. doi: 10.1016/j.jaad.2026.04.1972. Epub ahead of print. PMID: 42061618.

Tags: anogenital region, cancer screenings, Dermatology, ethics, genital exam, human papilloma virus (HPV), informed consent, medical legal liability, melanoma, patient autonomy, penile, Publications, Resident, skin of color (SOC), squamous cell carcinoma, Total body skin examination (TBSE), vulvar

Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double-Blind, Phase 3 POETYK PsA-2 Trial

Mease PJ, Chandran V, Armstrong AW, Blanco R, Ogdie A, Siegel EL, Gottlieb AB, Zeng X, Thaçi D, Kishimoto M, Schulze-Koops H, Kivitz A, Dokoupilová[...]

ADAR1 loss-of-function variants altering RNA editing define a new interferon-dependent psoriasis subtype

Assan F, Tragin M, Marella S, Lipecka J, Roger K, Zarhrate M, Bondet V, Nguyen V, Akroun F, Nitschké P, Guerrera IC, Bole C, Izmiryan[...]

A practical inflammatory blood-cell marker for cardiovascular risk stratification in psoriasis: Development of the Platelet-Leukocyte Adjusted Cardiovascular (PLAC) score

Cortes JA, Aflatooni S, Ure A, Palma G, Johnsen N, Smart K, Nong Y, Armstrong AW. A practical inflammatory blood-cell marker for cardiovascular risk stratification[...]